Compare Natera Inc. Common Stock (NTRA) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Unity Software Inc — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while Unity Software Inc trades at $41.12 (market cap $20.52B). The key difference: Natera Inc. Common Stock is far larger — about 2.8× Unity Software Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Unity Software Inc for 50 Days on average.
| NTRA | U | |
|---|---|---|
Market Cap | $57.03B | $20.52B |
Volume | 1,131,157 | 4,656,122 |
Sector | Health | Technology |
52-Week High | $425.64 | $49.47 |
52-Week Low | $179.42 | $17.13 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $56.18B | $20.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Unity Software (U) trades at $41.40, down 11.31% over 24 hours, with a bullish technical outlook despite recent volatility. The company shows improving fundamentals with revenue stabilizing around $1.8B and narrowing losses, while strategic partnerships like Meta VR support drive positive sentiment. Analyst consensus remains strongly bullish with 82.76% buy ratings and a $48.01 price target, representing 16% upside potential from current levels.
Unity presents a growth opportunity with accelerating strategic revenue and margin expansion, though persistent net losses and high valuation multiples pose risks. The stock's outlook depends on continued execution of the advertising platform transformation and VR market penetration, with technical support at $45-46 providing near-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
